DCP Share Price Performance
R0
-37.29 (-100.00%)
Price R0
Fair ValueR46.20
Share Pricen/a
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Nov 22
Dis-Chem Pharmacies Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 28 Fair Values set on narratives written by author
DCP Community Narratives
AN
Fair Value R46.2 24.1% undervalued intrinsic discount
Accelerated Store Rollouts Will Capture Aging And Digital Demand
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value R39.7 11.7% undervalued intrinsic discount
Expanding Into Underrepresented Areas And Digital Health Will Strengthen Market Position In ZA Retail
1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
AN
Fair Value R29 20.9% overvalued intrinsic discount
Rising Costs Will Intensify Retail Saturation In South Africa
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Accelerated Store Rollouts Will Capture Aging And Digital Demand
Key Takeaways Rapid expansion and advanced automation are set to boost revenue growth, accelerate store profitability, and significantly improve operating leverage and net margins. Strategic positioning for demographic trends and digital health innovation will drive recurring revenue, higher market share, and sustainable earnings growth above competitors.Read more
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
R46.2
24.1% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue
14.94% p.a.
Profit Margin
3.11%
Future PE
34.47x
Price in 2028
R74.49
Expanding Into Underrepresented Areas And Digital Health Will Strengthen Market Position In ZA Retail
Key Takeaways Strategic expansion and enhanced cost management are driving revenue and net margin growth, with significant investment in new property and underrepresented areas. Focus on health care integration and digital strategies is boosting customer retention and recurring revenues, enhancing overall profitability and market presence.Read more
1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
AN
R39.7
11.7% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
10.66% p.a.
Profit Margin
3.28%
Future PE
31.45x
Price in 2028
R63.98
Rising Costs Will Intensify Retail Saturation In South Africa
Key Takeaways Aggressive store expansion and rising operational costs risk compressing margins and could undermine growth if market saturation and cost pressures persist. Dependence on discretionary spending and regulated dispensary income increases vulnerability to economic downturns, regulation changes, and heightened digital and retail competition.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
R29
20.9% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
10.59% p.a.
Profit Margin
3.48%
Future PE
21.67x
Price in 2028
R46.72
Trending Discussion
Recently Updated Narratives
AN
Rising Costs Will Intensify Retail Saturation In South Africa
Fair Value: R29 20.9% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Accelerated Store Rollouts Will Capture Aging And Digital Demand
Fair Value: R46.2 24.1% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Expanding Into Underrepresented Areas And Digital Health Will Strengthen Market Position In ZA Retail
Fair Value: R39.7 11.7% undervalued intrinsic discount
12 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Dis-Chem Pharmacies Limited Key Details
Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
May 29, 2026
- 1.44
- 22.40%
- 3.02%
- 46.9%
About DCP
- Founded
- 1978
- Employees
- n/a
- CEO
- WebsiteView website
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market. In addition, it offers customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.
